Oma Fertility aims to improve in‑vitro fertilization by combining better technology with respectful care and ethical pricing. The company was founded by Gurjeet Singh in 2020. Oma has raised $71.5 million across three funding rounds. Chrissy Meyer and Root Ventures invested in the last two rounds. The company is actively engaging in public outreach—its founder and an investor are scheduled to speak at a TechCrunch Live event. The articles emphasize its mission to make IVF more accessible and patient‑centered. Oma Fertility combines artificial intelligence and robotics with clinical care to reduce the cost and human error associated with IVF. Its initial product, Oma Sperm InSight™, uses AI to identify the most promising sperm cells to improve embryo quality and boost success rates. The company opened its first clinic in Santa Barbara, California in 2021 and announced plans to expand nationally through 2023. Co-founder and CCO Dr. Sahil Gupta previously founded the Aveya clinic chain in India and Nepal and brought demonstrated operational experience to the venture. Oma positions a team of engineers and physicians together to automate manual lab tasks and standardize assessments where embryologists historically disagree. The company markets its approach as making fertility treatments more accessible and affordable compared with typical U.S. IVF pricing.

Total raised

$109M

Funding rounds

3

Latest round

Equity

Latest activity

Mar 2023